1 withdrawn. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Withdrawn 1 |
Follow Urethral Neoplasms: new trials by email Literature Review of Urethral Neoplasms trials Research Report on Urethral Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Gemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Urothelial Cancer cisplatin, gemcitabine hydrochloride, methotrexate - Anterior Urethral Cancer, Localized Transitional Cell Cancer of the Renal Pelvis and Ureter | Phase 2 | Withdrawn | University of Southern California | 2013-05-01 | 2014-01-29 |
Ureteral Neoplasms (1) · Urinary Bladder Neoplasms (1)
Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Male Urogenital Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Ureteral Diseases (1) · Urethral Diseases (1) · Urinary Bladder Diseases (1) · Urogenital Diseases (1) · Urogenital Neoplasms (1) · Urologic Diseases (1) · Urologic Neoplasms (1)
Cisplatin (1) · Doxorubicin (1) · Gemcitabine (1) · Methotrexate (1) · Vinblastine (1) · merphos (1) · pegfilgrastim (1)
University of Southern California (1)
Tanya Dorff (1)